간행물

생화학분자생물학회입니다.


EMM

Regulation of Common Neurological Disorders by Gut Microbial Metabolites

  • 작성자

    Chang H. Kim
  • 작성일자

    2022-03-24
  • 조회수

    301
Chang H. Kim( chhkim@umich.edu )
2017-present Professor, Department of Pathology, University of Michigan, USA
2017-present Betz Endowed Professor, Mary H Weiser Food Allergy Center, University of Michigan, USA
2002-2017 Assistant, Associate and Full Professor, Department of Pathobiology, Purdue University, USA
1999-2002 Postdoctoral fellow, Department of Pathobiology, Stanford University, USA
1995-1998 PhD, Department of Microbiology and Immunology, Indiana University, USA
1986-1992 BS, MS, Department of Biology/Biological Engineering, KAIST, Korea

Regulation of Common Neurological Disorders by Gut Microbial Metabolites

The gut is connected to the CNS by immunological mediators, lymphocytes, neurotransmitters, microbes and microbial metabolites. A mounting body of evidence indicates that the microbiome exerts significant effects on immune cells and CNS cells. These effects frequently result in the suppression or exacerbation of inflammatory responses, the latter of which can lead to tissue damage, altered synapse formation and disrupted maintenance of the CNS. Herein, we review recent progress in research on the microbial regulation of CNS diseases with a focus on major gut microbial metabolites, such as short-chain fatty acids, tryptophan metabolites, and secondary bile acids. Pathological changes in the CNS are associated with dysbiosis and altered levels of microbial metabolites, which can further exacerbate various neurological disorders. The cellular and molecular mechanisms by which these gut microbial metabolites regulate inflammatory diseases in the CNS are discussed. We highlight the similarities and differences in the impact on four major CNS diseases, i.e., multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, and autism spectrum disorder, to identify common cellular and molecular networks governing the regulation of cellular constituents and pathogenesis in the CNS by microbial metabolites.

Experimental & Molecular Medicine (2021) 53:1821–1833
https://doi.org/10.1038/s12276-021-00703-x